Funding · Biotech
PorMedTec raises ¥1.01 billion for xenotransplantation research
The Japanese biotech is producing gene-edited donor pigs for planned kidney-transplant studies with two hospital partners.
Preparing donor pigs for clinical studies
PorMedTec uses cloning technology to reproduce gene-edited pigs developed for xenotransplantation. The genetic modifications are intended to reduce immune rejection and address the risk of porcine endogenous retrovirus transmission. The company is preparing kidney-transplant studies with Hokkaido University Hospital and Shonan Kamakura General Hospital, targeting a 2028 trial start.
Use of funds
Develop clinical application of xenotransplantation, including genetically modified donor-pig kidneys
Funding history
Funding · This round¥1B